Literature DB >> 17535870

Effect of amiodarone and dronedarone administration in rats on thyroid hormone-dependent gene expression in different cardiac components.

I Stoykov1, H C van Beeren, A F M Moorman, V M Christoffels, W M Wiersinga, O Bakker.   

Abstract

OBJECTIVE: In view of their different actions on thyroid hormone receptor (TR) isoforms we set out to investigate whether amiodarone (AM) and dronedarone (Dron) have different and/or component-specific effects on cardiac gene expression.
DESIGN: Rats were treated with AM or Dron and the expression of TRalpha 1, TRalpha 2, TRbeta 1 and several tri-iodothyronine (T3)-regulated genes was studied in different parts of the heart, namely the right atrium (RA), left ventricular wall (LVW) and apex.
METHODS: Rats were treated for 14 days with 100 mg/kg body weight AM or Dron. The expression of TRalpha 1, TRalpha 2, TRbeta 1 and T3-regulated genes was studied using real-time PCR and non-radioactive in situ hybridisation.
RESULTS: AM and Dron affected TR expression in the RA similarly by decreasing TRalpha 1 and beta 1 expression by about 50%. In the LVW, AM and Dron decreased TRbeta 1 and, interestingly, AM increased TRalpha 1. In the apex, AM also increased TRalpha 2. The changes seen in T3-dependent gene expression are reminiscent of foetal reprogramming.
CONCLUSION: Taken together, our results indicate that AM and Dron have similar effects on the expression of TR isoforms in the RA, which could partly contribute to their ability to decrease heart rate. On the other hand, the more profound effect of AM appears on TR- and T3-dependent gene expression in the left ventricle suggests foetal reprogramming.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535870     DOI: 10.1530/EJE-07-0017

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

Review 1.  Amiodarone and the thyroid: a 2012 update.

Authors:  F Bogazzi; L Tomisti; L Bartalena; F Aghini-Lombardi; E Martino
Journal:  J Endocrinol Invest       Date:  2012-03-19       Impact factor: 4.256

2.  Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity.

Authors:  C Di Cosmo; G De Marco; P Agretti; E Ferrarini; A Dimida; P Falcetta; S Benvenga; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2021-11-30       Impact factor: 4.256

Review 3.  Novel approaches for pharmacological management of atrial fibrillation.

Authors:  Joachim R Ehrlich; Stanley Nattel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  Dronedarone.

Authors:  Sheridan M Hoy; Susan J Keam
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.

Authors:  Mitchell J Elliott; Katarzyna J Jerzak; Jessica G Cockburn; Zhaleh Safikhani; William D Gwynne; John A Hassell; Anita Bane; Jennifer Silvester; Kelsie L Thu; Benjamin Haibe-Kains; Tak W Mak; David W Cescon
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

Review 6.  The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.

Authors:  Wilmar M Wiersinga
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

7.  Thyroid Hormone Receptor α Mutations Cause Heart Defects in Zebrafish.

Authors:  Cho Rong Han; Hui Wang; Victoria Hoffmann; Patricia Zerfas; Michael Kruhlak; Sheue-Yann Cheng
Journal:  Thyroid       Date:  2020-09-25       Impact factor: 6.568

Review 8.  Dronedarone in the management of atrial fibrillation.

Authors:  Ts Mohamed Saleem; K Bharani; C Madhusudhana Chetty; K Gauthaman
Journal:  Open Access Emerg Med       Date:  2010-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.